Target and Its Patented Drug(s)

Content Navigation (  All   None )                                      
Target General Information
Patent(s) and the Corresponding Patented Drug(s)
References
Target General Information  Top
Target ID T98269 Target Info
Target Name Caspase-1 (CASP1)
Synonyms P45; Interleukin-1 beta-converting enzyme; Interleukin-1 beta converting enzyme; Interleukin-1 beta convertase; IL1BCE; IL1BC; IL-1BC; IL-1 beta-converting enzyme; IL-1 beta converting enzyme; ICE; CASP-1
Target Type Clinical trial Target
Gene Name CASP1
Biochemical Class Peptidase
UniProt ID
CASP1_HUMAN
Patent(s) and the Corresponding Patented Drug(s)  Top
World Intellectual Property Organization (WIPO)
Patent ID WO2015144183
Title Treatment of Contact Dermatitis.
Abstract The present invention provides a method for treating contact dermatitis by the topical administration of a caspase-1 inhibitor. The present invention further provides a pharmaceutical composition comprising a caspase-1 inhibitor for the treatment of contact dermatitis.
Applicant(s) University of Copenhagen
Representative Drug(s) D04KIH Drug Info N.A. Click to Show More [1]
2 D07AVV Drug Info N.A. [1]
United States Patent and Trademark Office (USPTO)
Patent ID US20140011847
Title Caspase Inhibitors and Uses Thereof.
Patent ID US9045524
Title Selective Caspase Inhibitors and Uses Thereof.
References  Top
REF 1 Caspase inhibitors: a review of recently patented compounds (2013-2015).Expert Opin Ther Pat. 2018 Jan;28(1):47-59.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.